Press Releases

Gates will address the devastating consequences of quality lapses in the aerospace industry in the second plenary session on Sept. 18.

Crowd-favorite sessions like Center and Compliance Office Updates, Current CGMP Compliance Trends and Topics, and Lunch with the Regulators return!

The three confirmed FDA speakers are all from Center for Biologics Evaluation and Research (CBER) and include: Tiffany Lucas, PhD, Gene Therapy CMC Reviewer; Brenton K. McCright, PhD, Biologist; Mikhail V. Ovanesov, PhD, Branch Chief.

A new feature of the 2023 conference is a “free” night on Tuesday, April 4, to explore all New Orleans, La. has to offer. The Hyatt Regency New Orleans is walking distance to many of the city’s renowned tourist attractions, including the historic French Quarter, Arts District, and Mississippi Riverfront. There’s no better place from which to explore the eclectic vibrancy of New Orleans.

The first new PDA/Innerspace training course is called Fundamentals of Aseptic Processing, which will be held in Carlsbad, Calif., in July.

Industry experts leading the Interest Group will be Marcia Baroni, Emergent BioSolutions, Rebecca Brewer, Quality Executive Partners, Gabriele Gori, Thermo Fisher Scientific, and Stephen Langille, ValSource.

The 2023 PDA Annual Meeting, April 3-5, in New Orleans, La., is organized around the theme, “Back to the Future: Learning from The Past in A Patient-Centric World.” The meeting will spotlight the critical connection between our patients and the manufacturing process and enabling a patient-focused mindset on the manufacturing floor.

The Parenteral Drug Association, Inc. (PDA) and RX Global today announced the renewal of their Premier Association Sponsorship agreement for INTERPHEX 2023, taking place April 25-27, 2023, at the Javits Center in New York City. This is the tenth year PDA has served as a Premier Association Supporter.

PDA Announces the Volunteer Members of its 2023 Board of Directors and Officers

SmartSkin discussed manufacturing and quality assurance issues at the 2022 PDA/FDA Joint Regulatory Conference in Washington earlier this month and showcased its latest product innovations to PDA and FDA members. SmartSkin will also be attending the upcoming PDA Universe of Pre-Filled Syringes and Injection Devices show in Palm Springs, CA, October 18-19.

The largest conference/exhibition dedicated to this critical technology for the delivery of biological and traditional medicines returns to in-person meeting in 2022

Richard M. Johnson concludes an eventful and successful 13-year term at PDA's helm, handing the reins to Glenn E. Wright, PDA COO.

This year’s PDA/FDA Joint Regulatory Conference will emphasize the role of implementing effective quality systems to ensure an ongoing state of control throughout the pharmaceutical product lifecycle by vigilantly managing quality risks. The roles of robust systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management will be emphasized.

Ascendis A/S and Phillips-Medisize A/S received PDA's Innovation Award for the SKYTROFA® Auto-Injector. The Stevanato Group and Bexson Biomedical earned the the Partnership Innovation Award for the innovation Pain Management Therapy through On-Body Injector System.

Packed audience filled the seats of the plenary session and the lanes of the exhibit hall.

The Parenteral Drug Association (PDA) announces senior regulatory experts to speak during opening session of the 2022 PDA Annual Meeting, the first full in-person signature event held by PDA since 2019. The PDA Annual Meeting takes place at the Hyatt Regency in Dallas, Tx., April 4-6.

The Parenteral Drug Association (PDA) today announced the availability of ANSI/PDA Standard 02-2021 Cryopreservation of Cells for Use in Cell Therapies, Gene Therapies, and Regenerative Medicine Manufacturing: An Introduction and Best Practices Approach on How to Prepare, Cryopreserve, and Recover Cells, Cell Lines, and Cell-Based Tissue Products.

The Parenteral Drug Association (PDA) today announced the results of the 2021 Board of Directors Election for the term beginning January 1, 2022.

The Parenteral Drug Association (PDA) today announced the winners of the 2021 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2021 PDA Universe of Pre-Filled Syringes and Injection Devices.

The Parenteral Drug Association (PDA) today announced the availability of its newest membership type, the Early Career Professional.